Parties
Full legal names and entity types of sponsor, institution, principal investigator, and any subcontractors; include contact and billing details and authorized signatories to avoid ambiguity.
A precise Healthcare Research Agreement reduces regulatory risk, protects patient privacy, and aligns expectations across sponsors, institutions, and investigators. Clear terms for PHI handling, IRB approvals, and data ownership limit disputes and support reproducible, compliant research operations.
Identifying these roles early helps assign responsibilities for compliance, data security, and publishing rights.
Full legal names and entity types of sponsor, institution, principal investigator, and any subcontractors; include contact and billing details and authorized signatories to avoid ambiguity.
Detailed study description, procedures, timelines, deliverables, enrollment targets, and locations where research activities will occur to limit scope creep and support IRB review.
Specify data elements, PHI handling, deidentification standards, permitted secondary uses, data transfer methods, and retention schedules consistent with HIPAA and institutional policy.
Technical and administrative safeguards, encryption requirements, access controls, breach notification timelines, and obligations to execute a Business Associate Agreement when PHI is involved.
Ownership of study results, inventions, licensing rights, and procedures for disclosures, patent filings, and revenue sharing among collaborators.
Authorship criteria, review periods for manuscripts, obligations to register trials, and sponsor reporting requirements for adverse events or regulatory submissions.
| Field | Configuration |
|---|---|
| Signer Order | Role-based sequential signing for sponsor, PI, institution legal office. |
| Authentication | Email plus SMS code or stronger methods for high-risk PHI access. |
| Document Versioning | Enable version control and attach change summaries to avoid confusion. |
| Audit Trail | Capture IP, timestamps, and action logs for each signer event. |
Ensure the chosen vendor supports a HIPAA BAA, API access for records, and export to standard formats for archival.
Date when obligations and term begin; affects retention and reporting.
Planned first enrollment or data collection date.
Date by which IRB approval must be obtained for human subjects work.
Interim reports, safety reports, and final deliverable due dates.
Deadline to provide formal notice per termination clause.
Finalize terms and obtain internal approvals before execution.
Submit protocol and consent materials for institutional review board approval.
Collect signatures and finalize data access agreements.
Complete final reports, return or destroy data as agreed.
The institution standardized research contracts across clinics to accelerate trials and ensure HIPAA safeguards.
Optica used templates to onboard multiple investigator-initiated studies quickly.
| Criteria | Healthcare Research Agreement | Clinical Trial Agreement |
|---|---|---|
| Primary Purpose | observational or data studies | interventional drug/device testing |
| Regulatory Oversight | may require irb only | fda oversight often required |
| PHI Handling | data-sharing focused | often involves investigational product |
| Typical Signers | pi and institution | sponsor, site, and cro |
| signNow | DocuSign | Adobe Sign | PandaDoc | HelloSign | |
|---|---|---|---|---|---|
| Starting Price | $8/user/mo | $15/user/mo | $14/user/mo | $19/user/mo | $15/user/mo |
| Free Trial | 7-day free trial, no credit card required | No | No | Yes, limited | Yes, limited |
| Bulk Send | Yes | Yes | Yes | Yes | No |
| Audit Trail | Yes | Yes | Yes | Yes | Yes |
| HIPAA Compliant | Yes | Yes | Yes | No | No |